Ethris
Company that claims to be paving a new path from genes to therapeutic proteins using its messenger RNA technology platform
Bayern, Germanywww.ethris.com ↗
Total raised
€30M
€29,658,048
Funding rounds
3
Investors
3
distinct backers
Active since
2023-01
latest 2025-05
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood56
base rate 45% for Grant
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood14
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-09 | Grant | €10M | EU4Health Grant | View deal → |
| 2024-06-18 | Other | €4.7M | The Bill & Melinda Gates Foundation | View deal → |
| 2023-01-03 | Other | €15M | Cipla EU | View deal → |
Related news
Similar companies
same sector or country- Delivery Hero€7.3BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Celonis€2.1BGermany · Software